Wed. 28 Feb 2024, 5:21pm ET
Benzinga
Earnings, News
Portage Biotech (NASDAQ:PRTG) reported quarterly losses of $(1.88) per share which missed the analyst consensus estimate of $(0.27) by 596.3 percent. This is a 327.27 percent decrease over losses of $(0.44) per share from the same period last year.